CD4 and non-small cell lung carcinoma: Study reported that increasing numbers of CD4+ T cells correlated significantly with improved disease-specific survival and that a high density of stromal CD4+ T cells was a favorable independent prognostic factor in non-small cell lung cancer (NSCLC) patients [11].